Published in Med J Aust on November 16, 1998
Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ (2004) 1.82
Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial. Emerg Med J (2005) 0.86
Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians. Infect Control Hosp Epidemiol (2014) 0.81
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis (2008) 2.39
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2001) 2.34
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
Malaria acquired in Bali. Med J Aust (1995) 1.93
Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage--sensitive but not specific. J Antimicrob Chemother (2007) 1.88
Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother (2005) 1.81
Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother (2000) 1.79
The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children. Aust N Z J Med (2000) 1.69
Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet (2001) 1.60
Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis (2013) 1.60
Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother (2005) 1.58
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42
HIV in the suburbs. Med J Aust (1993) 1.38
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother (1996) 1.36
In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol (1995) 1.34
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis (2010) 1.32
High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother (2008) 1.29
A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis (2009) 1.25
Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol (1995) 1.25
In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent. Diagn Microbiol Infect Dis (1991) 1.19
Psittacosis--a review of 135 cases. Med J Aust (1988) 1.17
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust (2001) 1.15
Optimum treatment of staphylococcal infections. Drugs (1993) 1.13
Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA. J Clin Microbiol (2009) 1.09
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect (2013) 1.09
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. Pathology (1997) 1.09
Vancomycin vintage: my favourite DRESS. Intern Med J (2015) 1.08
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 1.07
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob Agents Chemother (2003) 1.07
It's time to move beyond trying to predict mortality using severity assessment tools in community-acquired pneumonia. Intern Med J (2014) 1.07
The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC. Antimicrob Agents Chemother (1997) 1.07
Dissemination and genetic context analysis of bla(VIM-6) among Pseudomonas aeruginosa isolates in Asian-Pacific Nations. Clin Microbiol Infect (2009) 1.02
Antibiotic resistance in Streptococcus pneumoniae. Med J Aust (2000) 1.02
Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards method. Diagn Microbiol Infect Dis (1996) 1.01
Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol (2008) 0.99
Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg Infect Dis (2000) 0.97
Disc susceptibility testing for thermomphilic campylobacters. Pathology (1997) 0.97
Assessing the risk of tuberculosis infection among healthcare workers: the Melbourne Mantoux Study. Melbourne Mantoux Study Group. Med J Aust (2001) 0.96
Smoking and varicella pneumonia. J Infect (1988) 0.95
Helicobacter pylori resistance to tetracycline. Lancet (1996) 0.95
Severe dapsone syndrome due to weekly maloprim. Lancet (1988) 0.93
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia. Clin Microbiol Infect (2013) 0.93
Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol (2009) 0.93
The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother (1999) 0.93
Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother (1997) 0.91
A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. Thorax (2000) 0.90
Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro. Antimicrob Agents Chemother (1996) 0.89
Hospital-in-the-home care: is it worth the hassle? Med J Aust (1998) 0.89
Evaluation of API Campy in comparison with conventional methods for identification of thermophilic campylobacters. J Clin Microbiol (1995) 0.88
Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing. J Infect (1997) 0.88
Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir. Antimicrob Agents Chemother (2013) 0.86
Selection of optimum laboratory tests for the identification of Moraxella catarrhalis. Pathology (1997) 0.85
Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro. J Antimicrob Chemother (1997) 0.84
Postantibiotic suppression of growth of erythromycin A-susceptible and -resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004. Antimicrob Agents Chemother (2000) 0.84
Is bactericidal activity of amoxicillin against Helicobacter pylori concentration dependent? Antimicrob Agents Chemother (1996) 0.84
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756. Int J Antimicrob Agents (2002) 0.83
beta-Lactam pharmacology in liver disease. J Antimicrob Chemother (1983) 0.83
Isoniazid toxicity in health care workers. Clin Infect Dis (1999) 0.83
Neurological complications of chlamydial infections: case report and review. Clin Infect Dis (1997) 0.83
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001. Antimicrob Agents Chemother (2004) 0.81
Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test. Pathology (2013) 0.81
Acute epiglottitis in adults. Anaesth Intensive Care (1984) 0.81
Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme. J Hosp Infect (2012) 0.81
The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia. Infect Control Hosp Epidemiol (2001) 0.81
Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Am J Trop Med Hyg (1999) 0.80
Can alcohol-based hand-rub solutions cause you to lose your driver's license? Comparative cutaneous absorption of various alcohols. Antimicrob Agents Chemother (2006) 0.79
Post-antibiotic growth suppression of linezolid against Gram-positive bacteria. J Antimicrob Chemother (2001) 0.79
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis (1997) 0.78
Acceptability of early discharge, hospital at home schemes. Treatments that can be safely and acceptably managed at home need to be defined. BMJ (1998) 0.78
Safety of imipenem in neonates. Pediatr Infect Dis J (1995) 0.78
Effect of anti-tuberculosis treatment on the tuberculin interferon-gamma response in tuberculin skin test (TST) positive health care workers and patients with tuberculosis. Int J Tuberc Lung Dis (2000) 0.78
Cure of Rhizopus sinusitis in a liver transplant recipient with liposomal amphotericin B. Clin Infect Dis (1993) 0.77
Vibrio cholerae in Victoria. Med J Aust (2000) 0.77
Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clin Microbiol Infect (2012) 0.77
Low rates of cutaneous adverse reactions to alcohol-based hand hygiene solution during prolonged use in a large teaching hospital. Antimicrob Agents Chemother (2005) 0.77
Monoclonal gammopathy and septic arthritis. Aust N Z J Med (1999) 0.76
Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents. Pathology (2001) 0.76
Pneumococcal arthritis and monoclonal gammopathy of undetermined significance. Aust N Z J Med (1997) 0.76
Antibiotic use in livestock. Med J Aust (2000) 0.75
Still awaiting a useful tool for predicting severe CAP. Thorax (2006) 0.75
A potential "blind spot" in vancomycin treatment studies. Clin Infect Dis (2012) 0.75
The difference between biological warfare and bioterrorism: Australia finally makes a start towards real preparedness for bioterrorism. Intern Med J (2003) 0.75
Toxicities of flucloxacillin and dicloxacillin--is there really a difference? Med J Aust (2000) 0.75
Malaria acquired in Bali. Med J Aust (1995) 0.75
A review of isoniazid-related hepatotoxicity during chemoprophylaxis. Aust N Z J Med (1999) 0.75
A survey of cephalosporin use. Monitoring use in a hospital setting. Med J Aust (1979) 0.75
Outbreak of vancomycin-resistant Enterococcus faecium containing both vanA and vanB gene clusters. J Hosp Infect (2009) 0.75
Fistula-in-ano: don't forget tuberculosis. Med J Aust (1997) 0.75
Health care workers and tuberculosis. Aust N Z J Med (2000) 0.75